FieldScreen

proven technology to find new chemotypes

Smiling George Buckley

For a free evaluation simply talk to George
+44 1707 356 120
Chat with me

Using the information contained in known actives, FieldScreen™ finds new hits and leads from large databases. It has been employed within Cresset on 60+ projects with a success rate of 80% and is in daily use within several large pharmaceutical companies. Using FieldScreen you:

FieldScreen can be accessed by

Alternatively you could access FieldScreen using Cresset's highly cost effective services.

Unlike other virtual screening methods, FieldScreen requires very little information up front. We have had successful projects using as little as a single active compound as the input.

FieldScreen preferentially returns "lead-like" hits. In tests on the "DUD" dataset, FieldScreen preferentially retrieved molecules in the 350-370 MW range, significantly lower than other methods. This analytical test nicely mirrors Cresset's experience where we have consistently found lead like hits for our clients.

FieldScreen consistently out performs other methods when considering chemotype enrichment. This means a greater diversity of hits are delivered to your project.

FieldScreen is remarkably easy to use. Simply:

Studies on real client data have demonstrated its ability to find completely novel hits from screening just a few hundred compounds rather than hundreds of thousands. Successful collaborations have replaced peptide with non-peptide and steroid with non-steroid leads, as well as finding novel leads starting from known drug-like molecules.

Linux penguin

FieldScreen's easy to use web interface is great for most tasks. However, it can be readily customized by expert users to run and analyse searches automatically via the Linux command line.

FieldScreen will re-invigorate your drug discovery program. Talk to George about a free evaluation or let Cresset take the strain, our project services are a cost effective solution for finding new leads.